Skip to content 
AMM 280: Skin Beaute Med Spa Scandal: Counterfeit Botox Unveiled
November 30, 2024
This episode explores a major development in the field of aesthetic injectables, focusing on the efforts of an international Safety Task Force dedicated to improving patient safety. Comprising 16 experts from nine countries, the task force aims to standardize procedures and mitigate adverse events associated with procedures like fillers and neurotoxins. Key actions discussed include the overwhelming support for a global database to track adverse events and various safety techniques such as aspiration and the use of ultrasound and cannulas. The episode delves into the task force’s discussions on evolving treatment protocols for vascular adverse events, signaling a collaborative approach towards safer and more effective aesthetic practices.
Quick Takes
- An international Safety Task Force is focused on patient safety in aesthetic injectables
- The task force approved the establishment of a global database to track adverse events related to fillers
- Experts showed support for the use of aspiration as a safety technique during injections
Episode Transcript
Today is November 30, 2024. Let’s dive into a significant development in the realm of aesthetic injectables. An international Safety Task Force has been proactively addressing patient safety due to the soaring popularity of procedures like fillers and neurotoxins. Comprised of 16 experts from nine countries, this task force is a powerhouse of knowledge and aims to standardize procedures to mitigate adverse events associated with aesthetic injectables.
One of the key takeaways from their inaugural meeting was their overwhelming approval, with 93% in favor, of establishing a global database to track adverse events related to fillers. This initiative is aimed at enhancing data standardization and considering the inclusion of non-medical contributors to enrich the dataset. Additionally, 73% of the experts showed support for the use of aspiration as a safety technique during injections.
Notably, 43% of these experts currently use ultrasound in their procedures, albeit with divided opinions on its role as standard practice versus managing adverse events. The task force also noted that most of its members already employ cannulas for some injections, reflecting 93% adoption. Discussions continue on the best treatment practices for vascular adverse events and the need for evolving protocols to tackle these challenges effectively. This collaborative effort heralds a new era of enhanced safety and innovation in aesthetic medicine.
